Susceptibility of Runyon Group I Mycobacteria to rifampicin.
D006801:Humans; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects*; D009164:Mycobacterium Infections / Q000188:drug therapy; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D012874:Skin Diseases, Infectious / Q000188:drug therapy
D012293:Rifampin